Syngene is full scale Contract Development and Manufacturing Organization (CDMO) with extensive experience in serving the needs of both Small Molecules and Large Molecules industry. Our clients range from small and medium BioPharma to large BioPharma from all parts of the globe.
Our Development Services for Small Molecules encompass activities from pre-clinical to clinical trials including Drug Substance Development (DSP), Drug Product Development (DPD) and associated services to demonstrate safety, tolerability and efficacy of the selected drug candidate.
For Large Molecules Syngene provides end to end development services from cell line and process development through large scale production and supply of animal studies, clinical trial and commercial material. We offer one-stop shop support for the development of protein-based products for pharmaceutical and life sciences industries. Our capabilities cover recombinant proteins, monoclonal antibodies, glycoproteins, PEGylated proteins, multimeric protein complexes and antibody fragments
We have worked with microbial, mammalian as well as Hybridoma expression platforms with a variety of process technologies including intracellular soluble expression, inclusion body expression, and secreted proteins.